Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Cell Cycle
  • Prostatic Neoplasms

abstract

  • For conservatively managed patients, the CCP score is the strongest independent predictor of cancer death outcome yet described and may prove valuable in managing clinically localised prostate cancer.

publication date

  • March 13, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3304411

Digital Object Identifier (DOI)

  • 10.1038/bjc.2012.39

PubMed ID

  • 22361632

Additional Document Info

start page

  • 1095

end page

  • 9

volume

  • 106

number

  • 6